AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

STARPHARMA HOLDINGS LTD

0.750

+0.0050.67%

Volume:1.11M

Turnover:826.14K

Market Cap:357.79M

PE:-44.12

High:0.752

Open:0.745

Low:0.735

Close:0.745

52wk High:0.830

52wk Low:0.117

Shares:477.05M

Float Shares:347.84M

Volume Ratio:0.59

T/O Rate:0.32%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.017

EPS(LYR):-0.020

ROE:-45.55%

ROA:-21.00%

PB:25.97

PE(LYR):-37.50

Loading ...

Overview Company News Filings

Company Profile

Company Name:

STARPHARMA HOLDINGS LTD

Exchange:

ASX

Establishment Date:

1997

Employees:

50

Office Location:

4-6 Southampton Crescent,Abbotsford,Victoria,Australia

Website:

http://starpharma.com

Zip Code:

3067

Phone:

Fax:

61 3 9510 5955

Introduction:

Starpharma Holdings Limited engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company focuses on the development of VivaGel, which has completed Phase III clinical trials for the management and prevention of bacterial vaginosis, and as a condom coating for the prevention of sexually transmitted infections, as well as VivaGel condom, an antiviral condom. It also develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase 1/2 clinical trial, and DEP irinotecan that is in phase 1/2 clinical trials for the treatment of solid tumors. The company was founded in 1996 and is headquartered in Abbotsford, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/SPL.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"SPL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SPL.AU\",,,,,undefined,":{"symbol":"SPL.AU","market":"AU","secType":"STK","nameCN":"STARPHARMA HOLDINGS LTD","latestPrice":0.75,"timestamp":1789533551090,"preClose":0.745,"halted":0,"volume":1114413,"delay":0,"changeRate":0.00671140939597316,"nameEN":"STARPHARMA HOLDINGS LTD","floatShares":347835291,"shares":477054949,"eps":-0.017,"marketStatus":"Trading","change":0.005,"latestTime":"09-16 14:41:45 AEST","open":0.745,"high":0.752,"low":0.735,"amount":826141,"amplitude":0.022819,"askPrice":0.755,"askSize":83285,"bidPrice":0.745,"bidSize":176909,"shortable":3,"etf":0,"ttmEps":-0.017,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789538400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.745,"openAndCloseTimeList":[[1789516800000,1789538400000]],"volumeRatio":0.589637,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"SPL.AU","preClose":0.745,"auctionPrice":0.745,"auctionVolume":840,"auctionTime":1789516746234,"referenceTime":1789468203091,"auction":1,"marketStatus":"盘前竞价","timestamp":1789516746234}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SPL.AU\",,,,,undefined,":{"symbol":"SPL.AU","floatShares":347835291,"roa":"-21.00%","roe":"-45.55%","lyrEps":-0.02,"volumeRatio":0.589637,"shares":477054949,"dividePrice":0,"high":0.752,"amplitude":0.022819,"preClose":0.745,"low":0.735,"week52Low":0.117,"pbRate":"25.97","psRate":"28.24","week52High":0.83,"institutionHeld":0,"latestPrice":0.75,"committee":0.359824,"eps":-0.017,"divideRate":0,"volume":1114413,"delay":0,"ttmEps":-0.017,"open":0.745,"prevYearClose":0.351,"prevWeekClose":0.705,"prevMonthClose":0.72,"prevQuarterClose":0.682,"fiveDayClose":0.81,"twentyDayClose":0.725,"sixtyDayClose":0.682},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPL.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2026-07-17","symbol":"SPL.AU","defaultRemindTime":1784246400000,"type":"split","dateTimestamp":1784210400000,"forFactor":974214,"toFactor":1000000,"ratio":0.974214}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPL.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":4493458,"yearFounded":1997,"employeeNum":50,"address":"4-6 Southampton Crescent,Abbotsford,Victoria,Australia","zipCode":"3067","officePhone":"61 3 8532 2700","officeFax":"61 3 9510 5955","fiscalYearEnd":"06-30"},"stockCompanyDetail":{"websiteUrl":"http://starpharma.com","stockEarnings":[{"period":"1week","weight":-0.0802},{"period":"1month","weight":0.0276},{"period":"3month","weight":0.0924},{"period":"6month","weight":0.6629},{"period":"1year","weight":5.1066},{"period":"ytd","weight":1.1225}],"compareEarnings":[{"period":"1week","weight":-0.0053},{"period":"1month","weight":-0.0182},{"period":"3month","weight":0.0233},{"period":"6month","weight":0.0685},{"period":"1year","weight":0.0981},{"period":"ytd","weight":0.0357}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Starpharma Holdings Limited engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company focuses on the development of VivaGel, which has completed Phase III clinical trials for the management and prevention of bacterial vaginosis, and as a condom coating for the prevention of sexually transmitted infections, as well as VivaGel condom, an antiviral condom. It also develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase 1/2 clinical trial, and DEP irinotecan that is in phase 1/2 clinical trials for the treatment of solid tumors. The company was founded in 1996 and is headquartered in Abbotsford, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.019366},{"month":2,"riseRate":0.346154,"avgChangeRate":-0.019367},{"month":3,"riseRate":0.384615,"avgChangeRate":0.02555},{"month":4,"riseRate":0.307692,"avgChangeRate":-0.017937},{"month":5,"riseRate":0.346154,"avgChangeRate":-0.039405},{"month":6,"riseRate":0.576923,"avgChangeRate":0.041309},{"month":7,"riseRate":0.423077,"avgChangeRate":0.002565},{"month":8,"riseRate":0.692308,"avgChangeRate":0.096765},{"month":9,"riseRate":0.5,"avgChangeRate":0.017785},{"month":10,"riseRate":0.461538,"avgChangeRate":-0.016562},{"month":11,"riseRate":0.5,"avgChangeRate":0.028116},{"month":12,"riseRate":0.461538,"avgChangeRate":-0.006043}],"exchange":"ASX","name":"STARPHARMA HOLDINGS LTD","nameEN":"STARPHARMA HOLDINGS LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SPL.AU\",market:\"AU\",,,undefined,":null}}